Detection of residual disease by immunostaining of bone marrow trephines (BMT) after 2-chlorodeoxyadenosine (CDA) in previously untreated chronic lymphocytic leukemia (CLL).
Gala, J.-L., Ferrant, A., Delannoy, A., Martiat, P., Rodhain, J., Scheiff, J.-M., Chenut, F., Deneys, V., & Michaux, JL. (1995). Detection of residual disease by immunostaining of bone marrow trephines (BMT) after 2-chlorodeoxyadenosine (CDA) in previously untreated chronic lymphocytic leukemia (CLL). Blood, 86(10), 3320. (Original work published 1995)